Trial Profile

A pharmacodynamic study assessing BGE-105 in humans with those seen in previous trials examining the effects of the apelin peptide

Status: Recruiting

Phase of Trial: Phase I

Latest Information Update: 08 Dec 2022

Price :

$35 ^*

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

Drugs Azelaprag (Primary)
Indications Muscular atrophy
Focus Pharmacodynamics
Sponsors BioAge Labs

Most Recent Events

05 Dec 2022 According to a BioAge Labs media release, results from the trial will be will be discussed in a company hosted virtual event.
05 Dec 2022 Results published in a BioAge Labs media release.
19 Apr 2022 According to a BioAge Labs media release, following completion of the Phase 1b trial, company will proceed with phase 2 trial.

You need to be a logged in or subscribed to view this content

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial (opens in a new window)

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com